If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M

If GSK thrives in '25, CEO Emma Walmsley's pay could more than double to $27M

Source: 
Fierce Pharma
snippet: 

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report.

While it revealed that Walmsley took a 16% pay cut in 2024, it also laid out a new compensation plan which could make her one of the highest-paid chief executives in the industry this year.